Analysis of DNA Methylation Status in Bodily Fluids for Early Detection of Cancer

Epigenetic alterations by promoter DNA hypermethylation and gene silencing in cancer have been reported over the past few decades. DNA hypermethylation has great potential to serve as a screening marker, a prognostic marker, and a therapeutic surveillance marker in cancer clinics. Some bodily fluids...

Descripción completa

Detalles Bibliográficos
Autores principales: Yokoi, Keigo, Yamashita, Keishi, Watanabe, Masahiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412321/
https://www.ncbi.nlm.nih.gov/pubmed/28358330
http://dx.doi.org/10.3390/ijms18040735

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412321/
https://www.ncbi.nlm.nih.gov/pubmed/28358330
http://dx.doi.org/10.3390/ijms18040735

Ejemplares similares